AbbVie
-$0.20 (-0.17%) As of 2:09 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.
About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.
CEO
Richard A. Gonzalez
Employees
47,000
Headquarters
North Chicago, Illinois
Founded
2011
ABBV Key Statistics
Market Cap
207.67B
Price-Earnings Ratio
41.60
Dividend Yield
4.21
Average Volume
6.35M
High Today
$117.85
Low Today
$116.78
Open Price
$117.79
Volume
453.12K
52 Week High
$118.67
52 Week Low
$79.11
ABBV News
BenzingaJul 26
FDA Strikes Off Incyte's Retifanlimab Application In Anal Cancer - Incyte Genomics
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
AbbVie Inc (NYSE: ABBV) and Eli Lilly And Co (NYSE: LLY) will have to keep waiting
Analyst Ratings
74%
of 23 ratings
Buy
73.9%
Hold
21.7%
Sell
4.3%
ABBV Earnings
$0.00
$1.03
$2.06
$3.09
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$3.09 per share
Actual
Available Jul 30, Pre-Market